Increased plasma endothelin in diabetes:
an atherosclerosis marker?.
Dear Sir, Following an article in Diabetologia [1] , a letter [2] -and the response from the authors [3] -regarding the role of endothelin as a marker of endothelial dysfunction in diabetes mellitus have been published. We would like to present our own experience on this subject.
We have measured plasma endothelin levels in 79 diabetic patients [23 Type I (age 20-50 years) and 56 Type 2 (age 55-78 years)], and in 100 young (20-50 years) and 36 older (55-78 years) healthy control subjects.
In normotensive uncomplicated Type i diabetic patients (n : 13), the plasma endothelin levels were not significantly different from those of the age-matched control subjects. Microalbuminuria ( > 30 gg/ml; n = 10) and concomitant retinopathy together with well-preserved kidney function were associated with significantly elevated endothelin levels in Type i diabetic patients as compared with their age-matched control subjects (1.6 + 0.3 vs 0.54 _+ 0.39 pg/ml, p < 0.05). Our results show that endothelin levels increase with age in normal subjects (0.54_+0.39 pg/ml in the young vs 1.54_+ 0.9 pg/ml in the elderly, p < 0.01), and as could be expected, normotensive, normoalbuminuric Type 2 diabetic patients (n = 28) show endothelin levels which are not statistically different from those of the control subjects. Type 2 diabetic patients with microalbuminuria (n = 10), in contrast to their Type i counterparts, also have plasma endothelin levels which are comparable to those of control subjects.
However, when macrovascular disease (n = 16) was considered (peripheral and coronary artery diseases) in Type 2 diabetic patients, the plasma endothelin levels were found to be significantly elevated as compared with those of 40 Type 2 diabetic patients without vascular complications (1.56 + 0.6 vs 2.3 + 0.9 pg/ml, p < 0.01) [4] .
When retinopathy was investigated, the results continued to indicate that it is macrovascular disease which is inducing endothelin. Patients with retinopathy but without macrovascular disease (n = 10 of 40, endothelin 1.43 + 0.4) had endothelin levels which were not significantly different from those of the control group (1.54 + 0.9 pg/ml). Patients with retinopathy and macrovascular disease (n = 9 of 16) showed significantly elevated levels (2.5 +0.9 pg/ml, p < 0.01) [5] .
Diabetes is an atherogenic polygenic disease. In Type i diabetes there is a strong association between microalbuminuria and vascular disease [6] . This association is much less manifest in Type 2 diabetes, which itself is associated with the insulin-resistance syndrome [7] and also with the presence of other risk factors.
Our data clearly indicate that endothefin is increased in Type i diabetic patients with microalbuminuria and in Type 2 diabetic patients with overt atherosclerosis.
Further research is indicated to classify the role of endothelin as a marker of vascular dysfunction. 
Response from the authors
Dear Sir,
We thank Dr Patino and co-workers for their interesting data. They observed normal plasma endothelin concentrations in normotensive uncomplicated Type i diabetes. In contrast, we found that endothelin levels were lower in men with uncomplicated Type 1 diabetes than in male control subjects [1] . Plasma endothelin concentrations may be influenced by gender [2] . This finding [2] may explain the difference between our results [1] and those of Patino et al. It would, therefore, be interesting to reanalyse their data after stratification by sex.
The fact that Patino et al. found plasma endothelin concentrations to be elevated in patients with Type 1 diabetes complicated by microalbuminuria is consistent with a large body of evidence showing that such patients have generalised vascular and endothelial dysfunction [3, 4] .
It is somewhat surprising that Patino et al. observed normal endothelin levels in microalbuminuric (and normoalbuminuric) Type 2 diabetic patients. First, their data appear to be at variance with the largest study on this subject to date [5] . Second, the group of micr0albuminuric patients was relatively small, leaving open the possibility of a statistical type II error. Third, microalbuminuria is, in fact, very strongly associated with atherosclerotic vascular disease in Type 2 diabetes [6, 7] . Fourth, insulin stimulates endothelin production in vitro [8] , suggesting that it may be worthwhile to investigate the relationship between endothelin concentrations and insulin resistance and the hyperinsulinaemia that accompanies it.
In view of endothelin's widespread actions, we do agree that further study of its role in diabetic micro-and macroangiopathy is necessary. At present, however, the plasma concentration of von Willebrand factor, an endothelium-derived glycoprotein, seems to be the best available marker of endothelial injury in Type 2 diabetes [7] .
Yours sincerely, C. D. A. Stehouwer
